FI960077A - Uudet (1-fenyyli-1-heterosyklyyli) alkaanijohdannaiset ja niiden käyttö hermostoa suojaavina aineina - Google Patents

Uudet (1-fenyyli-1-heterosyklyyli) alkaanijohdannaiset ja niiden käyttö hermostoa suojaavina aineina Download PDF

Info

Publication number
FI960077A
FI960077A FI960077A FI960077A FI960077A FI 960077 A FI960077 A FI 960077A FI 960077 A FI960077 A FI 960077A FI 960077 A FI960077 A FI 960077A FI 960077 A FI960077 A FI 960077A
Authority
FI
Finland
Prior art keywords
heterocyclyl
phenyl
new
nervous system
protective agents
Prior art date
Application number
FI960077A
Other languages
English (en)
Swedish (sv)
Other versions
FI960077A0 (fi
Inventor
Bernard Robin Boar
Alan John Cross
Duncan Alastair Gray
Alfred Richard Green
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of FI960077A publication Critical patent/FI960077A/fi
Publication of FI960077A0 publication Critical patent/FI960077A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI960077A 1993-07-06 1996-01-08 Uudet (1-fenyyli-1-heterosyklyyli) alkaanijohdannaiset ja niiden käyttö hermostoa suojaavina aineina FI960077A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE19939302333A SE9302333D0 (sv) 1993-07-06 1993-07-06 New compounds
PCT/SE1994/000664 WO1995001967A1 (en) 1993-07-06 1994-07-05 Novel (1-phenyl-1-heterocyclyl)alkane derivatives and their use as neuroprotective agents

Publications (2)

Publication Number Publication Date
FI960077A true FI960077A (fi) 1996-01-08
FI960077A0 FI960077A0 (fi) 1996-01-08

Family

ID=20390540

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960077A FI960077A0 (fi) 1993-07-06 1996-01-08 Uudet (1-fenyyli-1-heterosyklyyli) alkaanijohdannaiset ja niiden käyttö hermostoa suojaavina aineina

Country Status (18)

Country Link
US (1) US5747515A (fi)
EP (1) EP0707573A1 (fi)
JP (1) JPH08512313A (fi)
CN (1) CN1044705C (fi)
AU (1) AU691191B2 (fi)
BR (1) BR9406924A (fi)
CA (1) CA2164876A1 (fi)
CZ (1) CZ4196A3 (fi)
FI (1) FI960077A0 (fi)
HU (1) HUT74673A (fi)
IS (1) IS1742B (fi)
NO (1) NO305862B1 (fi)
NZ (1) NZ268690A (fi)
PL (1) PL179021B1 (fi)
RU (1) RU2137763C1 (fi)
SE (1) SE9302333D0 (fi)
SK (1) SK281025B6 (fi)
WO (1) WO1995001967A1 (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2774596B1 (fr) * 1998-02-11 2000-03-17 Rhone Poulenc Rorer Sa Utilisation de composes selenies dans la prevention et le traitement de la maladie d'alzheimer
WO1999054309A1 (en) * 1998-04-23 1999-10-28 Takeda Chemical Industries, Ltd. Naphthalene derivatives, their production and use
US6503935B1 (en) 1998-08-07 2003-01-07 Abbott Laboratories Imidazoles and related compounds as α1A agonists
US6156775A (en) * 1999-03-01 2000-12-05 Novartis Ag Use of fluorinated triazoles in treating affective and attention disorders
AU5566400A (en) 1999-06-22 2001-01-09 Takeda Chemical Industries Ltd. Process for the preparation of imidazole derivatives
SE9904177D0 (sv) * 1999-11-18 1999-11-18 Astra Ab Novel compounds
WO2008064317A1 (en) * 2006-11-22 2008-05-29 University Of Medicine And Dentistry Of New Jersey Lipophilic opioid receptor active compounds
JP2014525442A (ja) * 2011-08-30 2014-09-29 ヴィアメット ファーマスーティカルズ,インコーポレイテッド 金属酵素阻害化合物
CN104932538B (zh) * 2015-07-03 2018-02-23 中国计量科学研究院 光机旋转装置

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE121520C (fi) *
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
US4649146A (en) * 1983-01-31 1987-03-10 Fujisawa Pharmaceutical Co., Ltd. Thiazole derivatives and pharmaceutical composition comprising the same
FR2625199B1 (fr) * 1987-12-23 1991-03-22 Irceba Derives oxyimino du thiazole, procede de preparation et utilisation en therapeutique
JPH01249760A (ja) * 1988-03-29 1989-10-05 Yamaha Corp ホトクロミック化合物
JPH0291076A (ja) * 1988-09-28 1990-03-30 Tokuyama Soda Co Ltd フォトクロミック性化合物及びその製造方法
TW224461B (fi) * 1990-09-18 1994-06-01 Ciba Geigy Ag
US5177079A (en) * 1991-01-31 1993-01-05 Warner-Lambert Company 2-substituted-4,6-di-tertiarybutyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
EP0569493A4 (en) * 1991-01-31 1993-11-24 Warner-Lambert Company Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines
GB9125924D0 (en) * 1991-06-18 1992-02-05 Orion Yhtymae Oy Stereoisomers of an imidazole derivative

Also Published As

Publication number Publication date
AU7197894A (en) 1995-02-06
CN1126990A (zh) 1996-07-17
PL179021B1 (pl) 2000-07-31
EP0707573A1 (en) 1996-04-24
IS4183A (is) 1995-01-07
NO960029L (no) 1996-01-04
SE9302333D0 (sv) 1993-07-06
HU9503742D0 (en) 1996-02-28
HUT74673A (en) 1997-01-28
US5747515A (en) 1998-05-05
CN1044705C (zh) 1999-08-18
PL312427A1 (en) 1996-04-29
AU691191B2 (en) 1998-05-14
NZ268690A (en) 1997-11-24
RU2137763C1 (ru) 1999-09-20
CA2164876A1 (en) 1995-01-19
JPH08512313A (ja) 1996-12-24
SK159995A3 (en) 1996-06-05
BR9406924A (pt) 1996-07-30
NO305862B1 (no) 1999-08-09
WO1995001967A1 (en) 1995-01-19
IS1742B (is) 2000-02-21
NO960029D0 (no) 1996-01-04
FI960077A0 (fi) 1996-01-08
CZ4196A3 (en) 1996-06-12
SK281025B6 (sk) 2000-11-07

Similar Documents

Publication Publication Date Title
FI934220A0 (fi) Piperidinderivat, framstaellning daerav och anvaendning daerav vid en terapi
DE69324506T2 (de) Gekühlte turbinenschaufel
FI970310A0 (fi) 4-indolijohdannaiset serotoniinin vaikuttaja- ja vastavaikuttaja-aineina
FI945662A0 (fi) Roerformad stomme, i synnerhet som hylselement och med hylselement foersedd stomme
FI933253A (fi) Nya amylinantagonistpeptider och anvaendning som amylinantagonister
NO20000366D0 (no) O-substituerte hydroksycoumaranon-derivater som anti-tumor- og antimetastase-midler
FI940166A0 (fi) Uusia adenosiinijohdannaisia
FI964936A0 (fi) Bentsopyraaneja ja niiden käyttö terapeuttisina aineina
FI960077A (fi) Uudet (1-fenyyli-1-heterosyklyyli) alkaanijohdannaiset ja niiden käyttö hermostoa suojaavina aineina
DE69521883T2 (de) Aromatische 2-amino-imidazolderivate als alpha 2a-adrenoceptor agonisten
EE03193B1 (et) (1-heteroasolüül-1-heterotsüklüül)alkaani derivaadid, nende saamise protsessid ja nende kasutamine närvisüsteemi kaitsvate vahendite valmistamiseks
FI932868A (fi) 2'-deoxi-2'2'-difluor(2,6,8-substituerade) purinnukleosider med virus-och cancerhaemmande aktivitet, samt mellanprodukter
FI960367A0 (fi) Uusia dialkoksipyridinyylibentsimidatsolijohdannaisia
FI964879A (fi) Uusia, 1,1-bis(heteroazolyyli)alkaanijohdoksia ja niiden käyttö hermostoa suojelevina aineina
DK0660715T3 (da) Carbostyrilderivater som antiarytmiske midler
FI923304A (fi) Nya bearbetbara tiofenbaserade polymerer och kopolymerer, och vaermestabila elledande kompositioner daerav
FI962019A (fi) Pyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina
FI942933A (fi) Uusia 3-halogeeni-5-halogeenimetyyli-2-oksatsolidinoneja ja niiden käyttö mikrobisideina
FI953520A0 (fi) Uudet substituoidut tiosemikarbatsonitionit
FR2700571B1 (fr) Support d'échafaudage volant.
DK124992A (da) Anhugningshoved
FI924813A0 (fi) Nya bis-isotiazoloner och deras anvaendning som mikrobicider
FI956318A0 (fi) Uudet ristisitojat ja niiden käyttö
NO951299D0 (no) Polyaminderivater som anti-cytomegalovirale midler
FI925490A0 (fi) Kopplingsschema foer sjaelverkande vaermeregulator i eluppvaermningsanordningar som anvaends i boningshus och frostskyddade utrymmen